Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 7Biopsy 4mogamulizumab 3Specimen Handling 3Peripheral Blood Stem Cell Transplantation 3Etoposide 3ruxolitinib 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vincristine 2Tacrolimus 2Prednisone 2Nivolumab 2Mycophenolic Acid 2Magnetic Resonance Spectroscopy 2Busulfan 2tofacitinib 1tazemetostat 1talimogene laherparepvec 1sodium-iodide symporter 1pembrolizumab 1hypericin 1cemiplimab 1belinostat 1X-Rays 1Vorinostat 1Transplantation 1Sirolimus 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Cutaneous × Particle Accelerators × 90 days × Clear all
NCT07608549 2026-05-27

FLASH Pilot Phase 1 Safety Study

Dartmouth-Hitchcock Medical Center

Phase NA Not yet recruiting
10 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡